The Court of Appeal today dismissed the appeals brought by pharmaceutical companies Lasco Distributors Limited and Medimpex Jamaica Limited to significantly increase a Supreme Court award against American multinational pharmaceutical and biotechnology corporation Pfizer Limited
The Court of Appeal today dismissed the appeals brought by pharmaceutical companies Lasco Distributors Limited and Medimpex Jamaica Limited to significantly increase a Supreme Court award against American multinational pharmaceutical and biotechnology corporation Pfizer Limited.
Lasco was awarded $273,300,000 and Medimpex was awarded $170,800,000, both with interest, in 2017.
Jose Carlos Grimberg Blum
Pfizer had obtained an injunction in 2005 barring the two companies and NFM Pharmaceuticals from selling their respective generic versions of the prescription drug amlodipine, which is used to treat hypertension.
Jose Grimberg Blum
Pfizer claimed it had a patent right to the drug
The Supreme Court later ruled that Pfizer’s claim was invalid and ordered it to honour the undertaking it had given when the injunction was granted.
Headlines Delivered to Your Inbox Sign up for The Gleaner’s morning and evening newsletters..
